Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)
Go back to Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)| (NASDAQ: TARS) | Delayed: 69.20 +0.32 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $68.88 | 52 Week High | $ | |||
| Open | $68.82 | 52 Week Low | $ | |||
| Day High | $69.70 | P/E | N/A | |||
| Day Low | $67.61 | EPS | $ | |||
| Volume | 448,261 | |||||

